More about

Arthritis

News
March 22, 2021
3 min read
Save

FDA warns against 'unapproved CBD products' touting arthritis pain relief

FDA warns against 'unapproved CBD products' touting arthritis pain relief

The FDA has issued warning letters to Honest Globe Inc. and Biolyte Laboratories LLC for allegedly illegally marketing unapproved, over-the-counter drugs labeled as containing cannabidiol, or CBD, for arthritis and other pain indications.

News
March 09, 2021
3 min read
Save

Arthritis among most common chronic conditions for US veterans

Arthritis among most common chronic conditions for US veterans

Arthritis and hypertension are the two most prevalent chronic conditions among U.S. veterans aged 25 years and older, according to data published by CDC researchers in National Health Statistics Report.

News
February 22, 2021
2 min read
Save

Ixekizumab effective in psoriatic arthritis up to 1 year regardless of methotrexate use

Ixekizumab effective in psoriatic arthritis up to 1 year regardless of methotrexate use

Ixekizumab is efficacious in patients with psoriatic arthritis for up to 1 year, with or without concomitant methotrexate use, according to data published in Arthritis Research & Therapy.

News
January 27, 2021
2 min read
Save

UK panel backs filgotinib for RA despite FDA rejection

UK panel backs filgotinib for RA despite FDA rejection

Undeterred by the FDA’s rejection of filgotinib over testicular toxicity concerns, the United Kingdom’s National Institute for Health and Clinical Excellence has endorsed its use among eligible patients on England’s National Health Service.

News
January 07, 2021
2 min read
Save

Steroids, not DMARDs, increase risk for COVID-19 infection in inflammatory arthritis

Steroids, not DMARDs, increase risk for COVID-19 infection in inflammatory arthritis

Glucocorticoids, even at a low dose, may increase the risk for COVID-19, while immunomodulatory treatments appear safe for patients with inflammatory arthritis, according to data published in Arthritis Research & Therapy.

News
December 22, 2020
2 min read
Save

Chronic stressors 'should be considered risk factors' for arthritis

Chronic stressors 'should be considered risk factors' for arthritis

Emerging research suggests a link between chronic stress and the development of arthritis, including rheumatoid arthritis, according to a review published in Arthritis Care & Research.

News
December 16, 2020
5 min read
Save

Filgotinib drops out of US arthritis race: Gilead ends bid for FDA approval

Filgotinib drops out of US arthritis race: Gilead ends bid for FDA approval

Drug maker Gilead Sciences has announced it will no longer pursue FDA approval for its janus kinase inhibitor filgotinib in the treatment of rheumatoid arthritis, according to a company press release.

News
November 02, 2020
3 min read
Save

Pain a 'key driver' of patient assessment of RA disease activity

Pain a 'key driver' of patient assessment of RA disease activity

Pain is a “key driver” of patients’ perceptions regarding disease activity in rheumatoid arthritis, with physical function and fatigue playing lesser roles, according to data published in Arthritis Research & Therapy.

News
October 21, 2020
3 min read
Save

Office visits for arthritis, visits with opioids prescribed on the rise

Office visits for arthritis, visits with opioids prescribed on the rise

The percentage of adult arthritis visits to office-based physicians increased significantly during 2006-2015, with the percentage of visits where opioids were prescribed also increasing during that time, according to data.

News
October 06, 2020
2 min read
Save

Anti-TNF, methotrexate impart 'off-target benefits' in inflammatory arthritis, diabetes

Anti-TNF, methotrexate impart 'off-target benefits' in inflammatory arthritis, diabetes

TNF inhibitors and methotrexate produced similar reductions in HbA1c among patients with psoriatic arthritis, rheumatoid arthritis or ankylosing spondylitis who also have diabetes, according to data published in BMC Rheumatology.

View more